Design, optimization and evaluation of domperidone coevaporates

Journal of Controlled Release

Volumn 63, Issue 1-2, 2000, Pages 31-39

  Nagarsenker, M S ^a   Garad, S D ^a   Ramprakash, G ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

Bioavailability; Coevaporates; Dissolution; Domperidone; Physical characterization

Indexed keywords

DOMPERIDONE;

ARTICLE; CONCENTRATION (PARAMETERS); DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG SOLUBILITY; INFRARED SPECTROPHOTOMETRY; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; X RAY DIFFRACTION;

ADULT; BIOLOGICAL AVAILABILITY; DELAYED-ACTION PREPARATIONS; DOMPERIDONE; DOPAMINE ANTAGONISTS; DRUG CARRIERS; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; SOLUBILITY; TABLETS; VOLATILIZATION;

EID: 0033972596     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(99)00177-7     Document Type: Article

References (10)

1. Reynolds J.E.F. 30th ed Martindale: the Extra Pharmacopoeia. 1993;882 The Pharmaceutical Press, London.
2. Naonori K., Yatabe H., Iseki K., et al. A new type of pH independent controlled release tablet. Int. J. Pharm. 68:1991;255.
3. Thomma K., Zimmer T. Retardation of weakly basic drug with diffusion tablet. Int. J. Pharm. 58:1990;197.
4. Nagarsenker M.S., Garad S.D. Physical characterization and optimisation of dissolution parameters of prochlorperazine maleate coevaporates. Int. J. Pharm. 160:1998;251.
5. Klisorova L., Goracinova K. Physical characterisation and dissolution properties of Verapamil HCl coprecipitates. Drug. Dev. Ind. Pharm. 21:(3):1995;383.
6. Nagarsenker M.S., Ramprakash G. Solid dispersion for extended release of Verapamil HCl. Pharm. Pharmacol. Commun. 4:(7):1998;331.
7. Chiou W.L., Reigelman R. Pharmaceutical applications of solid dispersions system. J. Pharm. Sci. 60:1971;1281.
8. Schwarts R., Connor E.O. Optimization technique in pharmaceutical formulation and processing. Banker G.S., Rhodes C.T. 3rd ed. revised and expanded Modern Pharmaceutics. 1996;727-751 Marcel Dekker, New York.
9. Banakar U.V., Lathia C.D., Wood J.H. Interpretation of dissolution rate data and techniques of in-vivo dissolution. Banakar U.V. Pharmaceutical Dissolution Testing. 1992;189-250 Marcel Dekker, New York.
10. Armstrong N.A., James K.C. Understanding experimental design and interpretation in pharmaceutics. 1990;37 Ellis Horwood, London.